Xieqiao Yan

Xieqiao Yan

UNVERIFIED PROFILE

Are you Xieqiao Yan?   Register this Author

Register author
Xieqiao Yan

Xieqiao Yan

Publications by authors named "Xieqiao Yan"

Are you Xieqiao Yan?   Register this Author

17Publications

536Reads

14Profile Views

Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.

Thorac Cancer 2019 Apr 12;10(4):950-956. Epub 2019 Mar 12.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Research Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/1759-7714.13034
Publisher Site
http://dx.doi.org/10.1111/1759-7714.13034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449256PMC
April 2019

Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.

Oncol Res 2019 Mar 3;27(4):495-501. Epub 2018 Aug 3.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, P.R. China.

View Article

Download full-text PDF

Source
http://www.ingentaconnect.com/content/10.3727/096504018X1533
Publisher Site
http://dx.doi.org/10.3727/096504018X15331163433914DOI Listing
March 2019

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients.

J Hematol Oncol 2019 01 14;12(1). Epub 2019 Jan 14.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Collaborative Innovation Center for Cancer Medicine, Beijing, China.

View Article

Download full-text PDF

Source
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-
Publisher Site
http://dx.doi.org/10.1186/s13045-018-0693-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332582PMC
January 2019

MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways.

Theranostics 2019 25;9(4):945-960. Epub 2019 Jan 25.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing 100142, China.

View Article

Download full-text PDF

Source
http://www.thno.org/v09p0945.htm
Publisher Site
http://dx.doi.org/10.7150/thno.30516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401396PMC
January 2019

Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report.

Chin Clin Oncol 2018 Dec 12;7(6):62. Epub 2018 Jul 12.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2018.06.08DOI Listing
December 2018

Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment Failure.

Transl Oncol 2018 Oct 26;11(5):1155-1159. Epub 2018 Jul 26.

Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080644PMC
October 2018

Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.

Eur J Cancer 2018 09 19;100:1-7. Epub 2018 Jun 19.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.04.007DOI Listing
September 2018

Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.

Ann Surg Oncol 2018 Aug 10;25(8):2184-2192. Epub 2018 May 10.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6503-9DOI Listing
August 2018

Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.

Ann Surg Oncol 2018 Apr 21;25(4):885-893. Epub 2017 Dec 21.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Collaborative Innovation Center of Cancer Medicine, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-6256-xDOI Listing
April 2018

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.

Clin Cancer Res 2017 Nov 22;23(22):6946-6957. Epub 2017 Aug 22.

Department of Renal Cancer and Melanoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-0070DOI Listing
November 2017

Pathway and Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases.

Clin Cancer Res 2017 Oct 18;23(20):6120-6127. Epub 2017 Jul 18.

The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0980DOI Listing
October 2017

GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.

Eur J Cancer 2016 09 4;65:156-63. Epub 2016 Aug 4.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Collaborative Innovation Center for Cancer Medicine, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.06.019DOI Listing
September 2016

Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis.

Oncotarget 2016 May;7(19):27044-54

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Collaborative Innovation Center for Cancer Medicine, Beijing, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053631PMC
http://dx.doi.org/10.18632/oncotarget.7395DOI Listing
May 2016

[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma].

Zhonghua Yi Xue Za Zhi 2015 Aug;95(30):2459-61

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China; Email:

View Article

Download full-text PDF

Source
August 2015

Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.

Br J Ophthalmol 2015 Jul 16;99(7):990-6. Epub 2015 Jan 16.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bjophthalmol-2014-305730DOI Listing
July 2015

[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib].

Zhonghua Yi Xue Za Zhi 2014 Oct;94(38):2988-91

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing 100142, China. Email:

View Article

Download full-text PDF

Source
October 2014